Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Smruthi OrganicsBOM:540686 -2.31%66 Days Payable is 87.22 as of Mar. 2026, which is 22% below its 10-year median of 111.86. GuruFocus rates BOM:540686 with a GF Score™ of 66/100 and a GF Value™ of ₹107.43 (Fairly Valued). The stock has 4 warning signs investors should review. Among 927 Drug Manufacturers companies, Smruthi Organics ranks better than 62.03% on this metric.
The historical rank and industry rank for Smruthi Organics's Days Payable or its related term are showing as below:
BOM:540686'
s Days Payable Range Over the Past 10 Years
Min: 55.68 Med: 111.86 Max: 129.86
Current: 110.25
During the past 13 years, Smruthi Organics's highest Days Payable was 129.86. The lowest was 55.68. And the median was 111.86.
BOM:540686's Days Payable is ranked better than 62.03% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs BOM:540686: 110.25
Smruthi Organics's Days Payable
increased
from Mar. 2025 (65.42) to Mar. 2026 (87.22).
It may suggest that Smruthi Organicsdelayed paying its suppliers.
Smruthi Organics Days Payable Related Terms
Smruthi Organics Days Payable Historical Data
* Premium members only.
The historical data trend for Smruthi Organics's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Smruthi Organics Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's Days Payable distribution charts can be found below:
* The bar in red indicates where Smruthi Organics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Smruthi Organics's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Smruthi Organics (BOM:540686) has a Days Payable of 87.22 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Smruthi Organics and its competitors. This is 22% below median its historical median of 111.86. Over the past decade, Smruthi Organics' Days Payable has ranged from 55.68 to 129.86. According to the industry distribution chart, Smruthi Organics ranks #352 out of 927 companies in the Drug Manufacturers industry, placing it in the top 38%.
Is Smruthi Organics' Days Payable too high?
Smruthi Organics' current Days Payable of 87.22 is 22% below median its 10-year median of 111.86. Over the past 10 years, this metric has ranged from a low of 55.68 to a high of 129.86. The Drug Manufacturers industry median Days Payable is 90.38. Smruthi Organics' value of 87.22 is 3.5% below this industry median. Based on the distribution chart, Smruthi Organics ranks #352 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Smruthi Organics has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Smruthi Organics' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Smruthi Organics ranks #352 out of 927 companies for Days Payable. This puts Smruthi Organics in the upper half of its industry. The industry median Days Payable is 90.38. Smruthi Organics' value of 87.22 is 3.5% below this benchmark. Historically, Smruthi Organics' own Days Payable has ranged from 55.68 to 129.86 over the past decade. While the company's 10-year median is 111.86 vs. the industry median of 90.38, Smruthi Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Smruthi Organics's current Days Payable of 87.22 is 3.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Smruthi Organics and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Smruthi Organics's current Days Payable is 87.22, which is 22% below median its own 10-year median of 111.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Smruthi Organics stock overvalued right now?
Based on GuruFocus' analysis, Smruthi Organics (BOM:540686) is currently considered Fairly Valued. The stock's GF Value™ is ₹107.43, compared to a current price of ₹116.05 — trading 8% above its estimated fair value. The current Days Payable is 87.22, which is 22% below median its 10-year median of 111.86 and 3.5% below the Drug Manufacturers industry median of 90.38. Smruthi Organics' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Smruthi Organics (BOM:540686), the current Days Payable is 87.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Smruthi Organics (BOM:540686) Overvalued in 2026?
Based on GuruFocus' analysis, Smruthi Organics stock appears to be overvalued.
The current stock price of ₹116.05 is trading 8% above its estimated GF Value™ of ₹107.43.
GuruFocus considers Smruthi Organics to be Fairly Valued.
Key valuation signals for BOM:540686:
Days Payable: 87.22 (22% below median its 10-year median of 111.86)
GF Value™: ₹107.43 vs. price of ₹116.05 (8% above fair value)
Industry Position: 3.5% below the Drug Manufacturers median (#352 of 927)
No single metric tells the full story. See the BOM:540686 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium, and many more. It has two reportable business segments: Bulk Drugs and Drugs Intermediates (API), and Formulation. It generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment. Geographically, the company generates maximum revenue from outside India through exports, and the rest from its business within India.
66GF Score
Get the complete analysis for BOM:540686
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540686 has been successfully added to your 
